Articles related to PATIENT SAFETY

The application of NIOSH Hazardous Drug Assessment principles to home healthcare is a critical development in ensuring safety. As home delivery of treatments like chemotherapy grows, understanding and implementing these principles become vital for healthcare professionals, patients, and their families. Explore how these principles are being adapted to protect all involved in this complex process.

Cipla’s recall of six batches of Albuterol Sulfate Inhalation Aerosol due to a container defect necessitates immediate attention for patient safety. Replacement inhalers must be obtained by consumers from these specific batches to prevent any potential adverse effects.

Amid emerging safety concerns, ADC Therapeutics has paused its mid-stage trial of Zynlonta, a potential game-changer in treating certain types of blood cancer, calling into question the drug’s future trajectory.

Gadoquatrane, a promising GBCA, enters Phase 3 clinical testing, potentially offering safer MRI procedures and advancing diagnostic capabilities for patients with CNS disorders, including MS.

Explore a comprehensive look at gabapentin, its mechanisms, widespread uses, potential side effects, and crucial factors to consider for ensuring patient safety and treatment efficacy.

As we navigate the digital age, the authenticity of online identities, especially within the medical field, is becoming increasingly critical. Learn more about the disturbing trend of online physician impersonation, its potential legal consequences, and how it’s threatening patient safety and medical trust.